SCOTTSDALE, AZ -- (MARKET WIRE) -- January 04, 2007 -- Medistem Laboratories, Inc. (OTCBB: MDSM), committed to the ethical development of next-generation medical therapies from non-controversial adult stem cell sources, announced today that Thomas Ichim, a veteran of the cell therapy industry with expertise in development and implementation of novel therapeutics in the area of biologics, has joined the Company as its Chief of Scientific Development.
